With the analysis among 1,019 patents, we discovered top 124 key players by total patent application. Genentech, Inc., Immunomedics, Inc., Novartis AG are dominant in this area. They take 26.40% of the total patent filing.
California, United States
Patent: 108
New Jersey, United States
Patent: 98
Basel-Stadt, Switzerland
Patent: 63
California, United States
Patent: 40
Cambridgeshire, United Kingdom
Patent: 36
Massachusetts, United States
Patent: 32
With the analysis among 92 patents, we discovered top 9 start-ups by total patent application. Autolus Ltd., Nanjing IASO Biotherapeutics Co., Ltd., DRAGONFLY Therapeutics, Inc. are active in this area.
Nanjing IASO Biotherapeutics Co., Ltd.
Jiangsu Sheng, China
Patent: 14
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 9
Institut National de la Santé et de la Recherche Médicale
Onechain Immunotherapeutics
Huadao (Shanghai) Biomedical Co., Ltd.
Shanghai Shi, China
Patent: 4
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 4
Mythic Therapeutics, Inc.
Massachusetts, United States
Patent: 4
Juventas Cell Therapy Ltd.
Tianjin Shi, China
Patent: 1
With the analysis among related 384 patents applied in the last 5 years. We discover 92 most active companies in this area. The fast-growing TeneoBio, Inc., Novartis AG, Lentigen Technology, Inc. take 24.22% of patent filing during this period.
California, United States
Patent: 40
Basel-Stadt, Switzerland
Patent: 31
Lentigen Technology, Inc.
Cambridgeshire, United Kingdom
Patent: 14
Nanjing IASO Biotherapeutics Co., Ltd.
Jiangsu Sheng, China
Patent: 14
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 14
New Jersey, United States
Patent: 13
Vaud, Switzerland
Patent: 10
With the analysis among related 384 patents in last 5 years, we discover 67 new entrants. TeneoBio, Inc., Lentigen Technology, Inc., Nanjing IASO Biotherapeutics Co., Ltd. are the most active new entrants in this area.
California, United States
Patent: 40
Lentigen Technology, Inc.
Nanjing IASO Biotherapeutics Co., Ltd.
Jiangsu Sheng, China
Patent: 14
Eureka Therapeutics, Inc.
California, United States
Patent: 10
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 9
Wuxi Cellular Biopharmaceutical Group Ltd.
Jiangsu Sheng, China
Patent: 7
Charité - Universitätsmedizin Berlin
California, United States
Patent: 7
With the analysis among 142 patents, we discovered top 22 universities and scientific research institutions by total patent application. Duke University, University of Birmingham, Charité - Universitätsmedizin Berlin are dominant in this area. They take 74.65% of the total patent filing.
North Carolina, United States
Patent: 18
Birmingham, United Kingdom
Patent: 9
Charité - Universitätsmedizin Berlin
University of Colorado Colorado Springs
Colorado, United States
Patent: 3
California, United States
Patent: 2
Friedrich-Alexander-Universität Erlangen-Nürnberg
Regents of the University of Colorado
Colorado, United States
Patent: 2